Abstract
Summary
The global market for Artificial Transcatheter Heart Valve was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Artificial Transcatheter Heart Valve was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Transcatheter Heart Valve was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Artificial Transcatheter Heart Valve was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Artificial Transcatheter Heart Valve include Edwards Lifesciences, Medtronic, Abbott, Livanova, Boston Scientific, Cryolife, Suzhou Jiecheng Medical Technology Co., Ltd., Labcor Laboratórios Ltda and Braile Biomédica, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Transcatheter Heart Valve, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Artificial Transcatheter Heart Valve by region & country, by Type, and by Application.
The Artificial Transcatheter Heart Valve market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Transcatheter Heart Valve.
Market Segmentation
By Company
Edwards Lifesciences
Medtronic
Abbott
Livanova
Boston Scientific
Cryolife
Suzhou Jiecheng Medical Technology Co., Ltd.
Labcor Laboratórios Ltda
Braile Biomédica
MicroPort Scientific Corporation
Beijing Balance Medical Technology Co., Ltd.
Myval
Segment by Type:
Aortic Heart Valve
Mitral Heart Valve
Tricuspid Heart Valve
Segment by Application
Aortic Stenosis
Aortic Regurgitation
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Artificial Transcatheter Heart Valve manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Artificial Transcatheter Heart Valve in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Artificial Transcatheter Heart Valve in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
North American market for Artificial Transcatheter Heart Valve was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Transcatheter Heart Valve was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Artificial Transcatheter Heart Valve was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Artificial Transcatheter Heart Valve include Edwards Lifesciences, Medtronic, Abbott, Livanova, Boston Scientific, Cryolife, Suzhou Jiecheng Medical Technology Co., Ltd., Labcor Laboratórios Ltda and Braile Biomédica, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Transcatheter Heart Valve, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Artificial Transcatheter Heart Valve by region & country, by Type, and by Application.
The Artificial Transcatheter Heart Valve market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Transcatheter Heart Valve.
Market Segmentation
By Company
Edwards Lifesciences
Medtronic
Abbott
Livanova
Boston Scientific
Cryolife
Suzhou Jiecheng Medical Technology Co., Ltd.
Labcor Laboratórios Ltda
Braile Biomédica
MicroPort Scientific Corporation
Beijing Balance Medical Technology Co., Ltd.
Myval
Segment by Type:
Aortic Heart Valve
Mitral Heart Valve
Tricuspid Heart Valve
Segment by Application
Aortic Stenosis
Aortic Regurgitation
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Artificial Transcatheter Heart Valve manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Artificial Transcatheter Heart Valve in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Artificial Transcatheter Heart Valve in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Artificial Transcatheter Heart Valve Product Introduction
1.2 Global Artificial Transcatheter Heart Valve Market Size Forecast
1.2.1 Global Artificial Transcatheter Heart Valve Sales Value (2019-2030)
1.2.2 Global Artificial Transcatheter Heart Valve Sales Volume (2019-2030)
1.2.3 Global Artificial Transcatheter Heart Valve Sales Price (2019-2030)
1.3 Artificial Transcatheter Heart Valve Market Trends & Drivers
1.3.1 Artificial Transcatheter Heart Valve Industry Trends
1.3.2 Artificial Transcatheter Heart Valve Market Drivers & Opportunity
1.3.3 Artificial Transcatheter Heart Valve Market Challenges
1.3.4 Artificial Transcatheter Heart Valve Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Artificial Transcatheter Heart Valve Players Revenue Ranking (2023)
2.2 Global Artificial Transcatheter Heart Valve Revenue by Company (2019-2024)
2.3 Global Artificial Transcatheter Heart Valve Players Sales Volume Ranking (2023)
2.4 Global Artificial Transcatheter Heart Valve Sales Volume by Company Players (2019-2024)
2.5 Global Artificial Transcatheter Heart Valve Average Price by Company (2019-2024)
2.6 Key Manufacturers Artificial Transcatheter Heart Valve Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Artificial Transcatheter Heart Valve Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Artificial Transcatheter Heart Valve
2.9 Artificial Transcatheter Heart Valve Market Competitive Analysis
2.9.1 Artificial Transcatheter Heart Valve Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Artificial Transcatheter Heart Valve Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Transcatheter Heart Valve as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Aortic Heart Valve
3.1.2 Mitral Heart Valve
3.1.3 Tricuspid Heart Valve
3.2 Global Artificial Transcatheter Heart Valve Sales Value by Type
3.2.1 Global Artificial Transcatheter Heart Valve Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Artificial Transcatheter Heart Valve Sales Value, by Type (2019-2030)
3.2.3 Global Artificial Transcatheter Heart Valve Sales Value, by Type (%) (2019-2030)
3.3 Global Artificial Transcatheter Heart Valve Sales Volume by Type
3.3.1 Global Artificial Transcatheter Heart Valve Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Artificial Transcatheter Heart Valve Sales Volume, by Type (2019-2030)
3.3.3 Global Artificial Transcatheter Heart Valve Sales Volume, by Type (%) (2019-2030)
3.4 Global Artificial Transcatheter Heart Valve Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Aortic Stenosis
4.1.2 Aortic Regurgitation
4.1.3 Others
4.2 Global Artificial Transcatheter Heart Valve Sales Value by Application
4.2.1 Global Artificial Transcatheter Heart Valve Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Artificial Transcatheter Heart Valve Sales Value, by Application (2019-2030)
4.2.3 Global Artificial Transcatheter Heart Valve Sales Value, by Application (%) (2019-2030)
4.3 Global Artificial Transcatheter Heart Valve Sales Volume by Application
4.3.1 Global Artificial Transcatheter Heart Valve Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Artificial Transcatheter Heart Valve Sales Volume, by Application (2019-2030)
4.3.3 Global Artificial Transcatheter Heart Valve Sales Volume, by Application (%) (2019-2030)
4.4 Global Artificial Transcatheter Heart Valve Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Artificial Transcatheter Heart Valve Sales Value by Region
5.1.1 Global Artificial Transcatheter Heart Valve Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Artificial Transcatheter Heart Valve Sales Value by Region (2019-2024)
5.1.3 Global Artificial Transcatheter Heart Valve Sales Value by Region (2025-2030)
5.1.4 Global Artificial Transcatheter Heart Valve Sales Value by Region (%), (2019-2030)
5.2 Global Artificial Transcatheter Heart Valve Sales Volume by Region
5.2.1 Global Artificial Transcatheter Heart Valve Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Artificial Transcatheter Heart Valve Sales Volume by Region (2019-2024)
5.2.3 Global Artificial Transcatheter Heart Valve Sales Volume by Region (2025-2030)
5.2.4 Global Artificial Transcatheter Heart Valve Sales Volume by Region (%), (2019-2030)
5.3 Global Artificial Transcatheter Heart Valve Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Artificial Transcatheter Heart Valve Sales Value, 2019-2030
5.4.2 North America Artificial Transcatheter Heart Valve Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Artificial Transcatheter Heart Valve Sales Value, 2019-2030
5.5.2 Europe Artificial Transcatheter Heart Valve Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Artificial Transcatheter Heart Valve Sales Value, 2019-2030
5.6.2 Asia Pacific Artificial Transcatheter Heart Valve Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Artificial Transcatheter Heart Valve Sales Value, 2019-2030
5.7.2 South America Artificial Transcatheter Heart Valve Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Artificial Transcatheter Heart Valve Sales Value, 2019-2030
5.8.2 Middle East & Africa Artificial Transcatheter Heart Valve Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Artificial Transcatheter Heart Valve Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Artificial Transcatheter Heart Valve Sales Value
6.2.1 Key Countries/Regions Artificial Transcatheter Heart Valve Sales Value, 2019-2030
6.2.2 Key Countries/Regions Artificial Transcatheter Heart Valve Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Artificial Transcatheter Heart Valve Sales Value, 2019-2030
6.3.2 United States Artificial Transcatheter Heart Valve Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Artificial Transcatheter Heart Valve Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Artificial Transcatheter Heart Valve Sales Value, 2019-2030
6.4.2 Europe Artificial Transcatheter Heart Valve Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Artificial Transcatheter Heart Valve Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Artificial Transcatheter Heart Valve Sales Value, 2019-2030
6.5.2 China Artificial Transcatheter Heart Valve Sales Value by Type (%), 2023 VS 2030
6.5.3 China Artificial Transcatheter Heart Valve Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Artificial Transcatheter Heart Valve Sales Value, 2019-2030
6.6.2 Japan Artificial Transcatheter Heart Valve Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Artificial Transcatheter Heart Valve Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Artificial Transcatheter Heart Valve Sales Value, 2019-2030
6.7.2 South Korea Artificial Transcatheter Heart Valve Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Artificial Transcatheter Heart Valve Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Artificial Transcatheter Heart Valve Sales Value, 2019-2030
6.8.2 Southeast Asia Artificial Transcatheter Heart Valve Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Artificial Transcatheter Heart Valve Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Artificial Transcatheter Heart Valve Sales Value, 2019-2030
6.9.2 India Artificial Transcatheter Heart Valve Sales Value by Type (%), 2023 VS 2030
6.9.3 India Artificial Transcatheter Heart Valve Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Edwards Lifesciences
7.1.1 Edwards Lifesciences Company Information
7.1.2 Edwards Lifesciences Introduction and Business Overview
7.1.3 Edwards Lifesciences Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Edwards Lifesciences Artificial Transcatheter Heart Valve Product Offerings
7.1.5 Edwards Lifesciences Recent Development
7.2 Medtronic
7.2.1 Medtronic Company Information
7.2.2 Medtronic Introduction and Business Overview
7.2.3 Medtronic Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Medtronic Artificial Transcatheter Heart Valve Product Offerings
7.2.5 Medtronic Recent Development
7.3 Abbott
7.3.1 Abbott Company Information
7.3.2 Abbott Introduction and Business Overview
7.3.3 Abbott Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Abbott Artificial Transcatheter Heart Valve Product Offerings
7.3.5 Abbott Recent Development
7.4 Livanova
7.4.1 Livanova Company Information
7.4.2 Livanova Introduction and Business Overview
7.4.3 Livanova Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Livanova Artificial Transcatheter Heart Valve Product Offerings
7.4.5 Livanova Recent Development
7.5 Boston Scientific
7.5.1 Boston Scientific Company Information
7.5.2 Boston Scientific Introduction and Business Overview
7.5.3 Boston Scientific Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Boston Scientific Artificial Transcatheter Heart Valve Product Offerings
7.5.5 Boston Scientific Recent Development
7.6 Cryolife
7.6.1 Cryolife Company Information
7.6.2 Cryolife Introduction and Business Overview
7.6.3 Cryolife Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Cryolife Artificial Transcatheter Heart Valve Product Offerings
7.6.5 Cryolife Recent Development
7.7 Suzhou Jiecheng Medical Technology Co., Ltd.
7.7.1 Suzhou Jiecheng Medical Technology Co., Ltd. Company Information
7.7.2 Suzhou Jiecheng Medical Technology Co., Ltd. Introduction and Business Overview
7.7.3 Suzhou Jiecheng Medical Technology Co., Ltd. Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Suzhou Jiecheng Medical Technology Co., Ltd. Artificial Transcatheter Heart Valve Product Offerings
7.7.5 Suzhou Jiecheng Medical Technology Co., Ltd. Recent Development
7.8 Labcor Laboratórios Ltda
7.8.1 Labcor Laboratórios Ltda Company Information
7.8.2 Labcor Laboratórios Ltda Introduction and Business Overview
7.8.3 Labcor Laboratórios Ltda Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Labcor Laboratórios Ltda Artificial Transcatheter Heart Valve Product Offerings
7.8.5 Labcor Laboratórios Ltda Recent Development
7.9 Braile Biomédica
7.9.1 Braile Biomédica Company Information
7.9.2 Braile Biomédica Introduction and Business Overview
7.9.3 Braile Biomédica Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Braile Biomédica Artificial Transcatheter Heart Valve Product Offerings
7.9.5 Braile Biomédica Recent Development
7.10 MicroPort Scientific Corporation
7.10.1 MicroPort Scientific Corporation Company Information
7.10.2 MicroPort Scientific Corporation Introduction and Business Overview
7.10.3 MicroPort Scientific Corporation Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2019-2024)
7.10.4 MicroPort Scientific Corporation Artificial Transcatheter Heart Valve Product Offerings
7.10.5 MicroPort Scientific Corporation Recent Development
7.11 Beijing Balance Medical Technology Co., Ltd.
7.11.1 Beijing Balance Medical Technology Co., Ltd. Company Information
7.11.2 Beijing Balance Medical Technology Co., Ltd. Introduction and Business Overview
7.11.3 Beijing Balance Medical Technology Co., Ltd. Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Beijing Balance Medical Technology Co., Ltd. Artificial Transcatheter Heart Valve Product Offerings
7.11.5 Beijing Balance Medical Technology Co., Ltd. Recent Development
7.12 Myval
7.12.1 Myval Company Information
7.12.2 Myval Introduction and Business Overview
7.12.3 Myval Artificial Transcatheter Heart Valve Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Myval Artificial Transcatheter Heart Valve Product Offerings
7.12.5 Myval Recent Development
8 Industry Chain Analysis
8.1 Artificial Transcatheter Heart Valve Industrial Chain
8.2 Artificial Transcatheter Heart Valve Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Artificial Transcatheter Heart Valve Sales Model
8.5.2 Sales Channel
8.5.3 Artificial Transcatheter Heart Valve Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer